ESPERARE

esperare-logo

As a private non-for-profit organisation, they strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drug to reach these underserved patients.

#SimilarOrganizations #People #Financial #Website #More

ESPERARE

Industry:
Biotechnology Life Science Non Profit Pharmaceutical

Founded:
2013-01-01

Address:
Plan-les-ouates, Geneve, Switzerland

Country:
Switzerland

Website Url:
http://www.esperare.org

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Mobile Non Scaleable Content Nginx Microsoft Exchange Online Office 365 Mail


Similar Organizations

antoxis-logo

Antoxis

Antoxis is developing treatments for various neurological conditions.

viramatix-logo

Viramatix

We develop therapeutics for viral diseases of unmet medical need.

Current Employees Featured

olivier-favre-bulle_image

Olivier Favre-Bulle
Olivier Favre-Bulle CMC Consultant @ EspeRare
CMC Consultant
2018-10-01

Investors List

eclosion-sa_image

Eclosion SA

Eclosion SA investment in Seed Round - EspeRare

Official Site Inspections

http://www.esperare.org Semrush global rank: 4.39 M Semrush visits lastest month: 2.55 K

  • Host name: cloudshared.vpsflex.net
  • IP address: 185.46.58.102
  • Location: Switzerland
  • Latitude: 47.1449
  • Longitude: 8.1551
  • Timezone: Europe/Zurich

Loading ...

More informations about "EspeRare"

Our mission and vision | EspeRare Foundation

Espe Rare is a not-for-profit organisation established in Switzerland in 2013. It is recognised to be operating in the public's interest. OUR VISION. We dream of a world in which patient engagement, good science, pharmaceutical excellence …See details»

Our focus | EspeRare Foundation

EspeRare concentrates its efforts on rare diseases that have the highest unmet medical needs and for which there is sufficient scientific understanding. Based on collaboration with …See details»

EspeRare foundation - LinkedIn

EspeRare is a not-for-profit organization established in Switzerland and recognized to be operating in the public interest. In collaboration with patient groups and other key stakeholders ...See details»

EspeRare Fondation - Swiss Biotech

EspeRare is an ethical non-profit biotech. It combines pharmaceutical know-how and philanthropic and public investments to bring to life treatments that have been abandoned by the …See details»

EspeRare foundation: Contact Details and Business Profile

EspeRare is a not-for-profit organization established in Switzerland and recognized to be operating in the public interest. In collaboration with patient groups and other key …See details»

EspeRare Foundation - CMOCRO

EspeRare is a Swiss non-profit organization that is committed to improve the lives of children with life-threatening rare diseases. EspeRare addresses the unmet medical needs of these …See details»

EspeRare Foundation - BioAlps

Organization Type . Foundation. Visit website Domains. Genetic Disease . Main sector. Biotech ... [email protected] . BioAlps Association. Avenue de Sécheron 15 1202 Geneva, …See details»

Our history | EspeRare Foundation

By establishing Espe Rare, we fulfil our dream of dedicating our pharma expertise to children battling rare diseases.. Founders of EspeRare: Florence Porte, Caroline Kant, Béatrice Greco Espe Rare was founded in 2013 by 3 former …See details»

EspeRare Foundation | European Clinical Trials Information Network

EspeRare Foundation is a non-profit organization that was founded in 2013 with the aim of developing treatments for rare. Menu. Search for Clinical Trials. Autoimmunity. Cancers. …See details»

EspeRare Foundation - Fundraiso

Fondation EspeRare is a charity that was founded in 2013 with legal form "Stiftung" in Switzerland. It operates in the topic research and science. Read the full mission. 4/2/2013. …See details»

Pierre Fabre Laboratories and the EspeRare Foundation to be …

Feb 15, 2024 On February 20, International Ectodermal Dysplasias Awareness Day, Pierre Fabre Laboratories and the EspeRare Foundation will receive the EURORDIS Company …See details»

Annette Verschuren - Wikipedia

Annette Verschuren, OC is a Canadian business woman. She is currently the Chair & Chief Executive Officer of NRStor Inc. [1] The company develops and manages energy storage …See details»

Development and Peace (Canada) - Wikipedia

Development and Peace, officially the Canadian Catholic Organization for Development and Peace [3] and also known as Caritas Canada [4] (in French: Organisation catholique …See details»

Annual reports | EspeRare Foundation

EspeRare foundation. As a private not-for-profit organisation, we strive to uncover the potential of existing molecules to address severe unmet therapeutic needs in rare diseases, thus giving …See details»

Americares is a Trusted Charity | Americares

Americares is approved by the Internal Revenue Service as a 501 (C) (3) tax-exempt organization, and all donations are tax deductible to the extent provided by law. Americares …See details»

Esperare foundation - Email Address & Phone Number - Lusha

Reach decision-makers at EspeRare foundation. Find their phone numbers & email addresses. It’s free. - LushaSee details»

Accueil | Fondation EspeRare

EspeRare est un acteur essentiel dans le système novateur et collaboratif qui sera créé pour faire la différence dans ce monde. Sharon Terry. Présidente d'EspeRare. Favoriser l’accès à des …See details»

OTI Festival 1974 - Wikipedia

OTI Festival 1974 was the third edition of the annual OTI Festival.It was held in Acapulco, Mexico, following the country's victory at the 1973 contest with the song "Que alegre va María" by …See details»

News | EspeRare Foundation

On June 25th 2024 starting at 9AM, EspeRare, a pioneering nonprofit biotech organization, will be featured at the Fongit Café Croissant event at Campus Biotech. During this session, …See details»

linkstock.net © 2022. All rights reserved